Xcout IntelCYduct Diagnostics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to CYduct Diagnostics, Inc. among medical - devices companies — ranked by similarity to what CYduct Diagnostics, Inc. actually does, not by market-cap band.
Subscribe to see CYduct Diagnostics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CYduct Diagnostics, Inc.
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
CYduct Diagnostics, Inc. at a glance
CYduct Diagnostics, Inc. is a medical - devices company headquartered in Westport, United States. It is publicly listed (CYDX) with a market capitalisation of $14.2M. Xcout tracks 5 named people at CYduct Diagnostics, Inc., including Dom L. Gatto (President, Chief Executive Officer, Secretary, Treasurer & Chairman).
CYduct Diagnostics, Inc. leadership
- Dom L. GattoPresident, Chief Executive Officer, Secretary, Treasurer & Chairman
- Fred V. SchiemannChief Financial Officer & Director
- Dom GattoFounder & CEO
- Dom L. GattoExecutive Officer
- Gerald SchwebelOperations Manager
Top 12 CYduct Diagnostics, Inc. competitors
Ranked by semantic similarity — how close each company is to CYduct Diagnostics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Devices
BiBB Instruments AB is a medical technology company that develops and manufactures EndoDrill®, a patented series of motorized endoscopic biopsy instruments designed to improve cancer diagnostics. The system uses an electric rotating needle technology to obtain high-quality core tissue samples during ultrasound-guided endoscopic procedures for various cancers, including gastrointestinal, lung, and urological malignancies.
Medical Devices
Medcaptain Medical Technology Co., Ltd. manufactures integrated perioperative medical devices in China, Europe, Asia, the Middle East, Africa, North America, and South America. It offers life support products, such as infusion systems, medication delivery products, anesthesia machines and vaporizers, workstations, imaging equipment, and other life support products, including airway management, pulmonary function testing devices, deep vein thrombosis (DVT) preventive pumps, vein illuminators, monitors, and veterinary life support products; minimally invasive intervention products, such as an endoscopic product portfolio for the diagnosis and treatment of conditions relating to the digestive system, including the gastrointestinal (GI) and hepatobiliary tracts, and the urological system; and In Vitro diagnostics products, such as thromboelastography analyzers, blood grouping analyzers, chemiluminescent immunoassay (CLIA) testing analyzers and reagent kits, and molecular diagnostics equipment and testing kits. The company sells its products through a chain of distributors globally. Medcaptain Medical Technology Co., Ltd. was formerly known as Shenzhen Yusheng Medical Technology Co., Ltd. and changed its name to Medcaptain Medical Technology Co., Ltd. in July 2023. Medcaptain Medical Technology Co., Ltd. was incorporated in 2011 and is based in Shenzhen, China.
Medical Devices
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
Medical Devices
URO-1, Inc. is a privately held medical device company established in 2017 and based in Greensboro, North Carolina. The company develops and manufactures surgical solutions and instruments for biopsy procedures, specifically focusing on prostate and soft tissue cancer diagnostics.
Medical Devices
Medimaging Integrated Solution Inc. specializes in delivering advanced digital and mobile diagnostic technology. The company engineers and produces a variety of digital handheld diagnostic scopes, alongside their essential auxiliary equipment. A key product line is the Horus scope system, which encompasses optical coherence tomography (OCT) capabilities, integrated control units, specialized software, and a full suite of accessories. Beyond hardware, Medimaging leverages artificial intelligence for screening applications, notably in detecting diabetic retinopathy, managing wound care, and supporting general medical diagnosis. They also provide comprehensive endoscopy solutions, utilizing advanced micro camera modules to ensure superior visualization and facilitate patient-focused care. These high-performance micro camera modules are also available as standalone components. Established in 2010, Medimaging Integrated Solution Inc. maintains its headquarters in Hsinchu City, Taiwan.
Medical Devices
Star Equity Holdings, Inc. operates as a diversified entity, providing healthcare solutions across the United States and globally. The company's business is structured into four primary segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. Within its diagnostic divisions, Star Equity offers imaging services mainly to cardiologists, internal medicine specialists, and family practitioners. It also supplies imaging systems, such as nuclear cardiac and general-purpose nuclear equipment, to medical offices and hospitals. Additionally, the company develops, sells, and maintains solid-state gamma cameras, providing comprehensive maintenance contract services for these devices. Its Construction segment is involved in manufacturing modular housing units, structural wall panels, permanent wood foundation systems, and various other engineered wood products, while also supplying building materials to general contractors. The Investments segment focuses on managing a portfolio of investments and holding real estate assets. Headquartered in Old Greenwich, Connecticut, Star Equity Holdings, Inc. was founded in 1985 and was formerly known as Digirad Corporation until its rebranding in December 2020.
Medical Devices
Laborie Medical Technologies Corp. is a medical technology company headquartered in Portsmouth, New Hampshire. The company specializes in medical devices and diagnostics for specialties such as urology and gastroenterology.
Medical Devices
3DBiopsy, Inc. operates as a medical device company that develops 3D mapping software, biopsy needles, biopsy actuators, and integrated pathology systems.
Medical Devices
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
Medical Devices
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency, high-resolution ultrasound device that delivers detailed imaging of the anterior segment of the eye, alongside the Pachymeter, which accurately measures corneal thickness. Beyond diagnostic tools, Escalon supplies intraocular gas products such as C3F8 and SF6, vital for vitreoretinal surgeons who utilize them as a temporary support during detached retina surgeries. To complement this, the firm produces and distributes a patented disposable universal gas kit, ensuring the efficient delivery of these gases from the canister to the patient. Furthermore, Escalon provides disposable surgical packs tailored for vitreoretinal procedures and offers the AXIS Image management system. This web-based platform enables the seamless organization and viewing of medical images from diverse devices, manufacturers, and locations. Escalon Medical Corp. distributes its products to medical institutions through a combination of independent sales representatives, an extensive network of distributors, and its dedicated internal sales personnel. Established in 1987, the company maintains its corporate headquarters in Wayne, Pennsylvania.
Medical Devices
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Medical Devices
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CYduct Diagnostics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CYduct Diagnostics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →